Drug intelligence / Profile preview

Ga-68 Galmydar

Development stage
Phase 1
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Ga-68 Galmydar is a radiopharmaceutical PET imaging tracer labeled with gallium-68, designed for noninvasive detection and assessment of myocardial injury, particularly chemotherapy-induced cardiotoxicity. It localizes to the mitochondria of heart cells, enabling sensitive molecular imaging of mitochondrial function and early metabolic changes in the myocardium. Ga-68 Galmydar has been evaluated preclinically for detecting doxorubicin-induced cardiomyopathy and is under clinical investigation for myocardial perfusion imaging (MPI), including quantification of myocardial blood flow in patients with suspected or known coronary artery disease. The agent demonstrates rapid blood clearance, stable retention in myocardium, favorable dosimetry, and metabolic stability[1][3][5][8].

Other names
68GA-Galmydar(68GA)GALMYDAR

Beyond the preview

Go deeper on Ga-68 Galmydar.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ga-68 Galmydar.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call